SwePub
Sök i LIBRIS databas

  Extended search

(id:"swepub:oai:DiVA.org:uu-91939")
 

Search: (id:"swepub:oai:DiVA.org:uu-91939") > Long-term imaging e...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Briley Saebo, KarenUppsala universitet,Institutionen för onkologi, radiologi och klinisk immunologi (author)

Long-term imaging effects in rat liver after a single injection of an iron oxide nanoparticle based MR contrast agent

  • Article/chapterEnglish2004

Publisher, publication year, extent ...

  • 2004-09-23
  • Wiley,2004
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-91939
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-91939URI
  • https://doi.org/10.1002/jmri.20175DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • PURPOSE: To investigate the duration of liver R2* enhancement and pharmacokinetics following administration of an iron oxide nanoparticle in a rat model.MATERIALS AND METHODS: Rats were injected with 0, 1, 2, or 5 mg Fe/kg of NC100150 Injection, and quantitative in vivo 1/T2* liver measurements were obtained between 1 and 133 days after injection. The concentration of NC100150 Injection was determined by relaxometry methods in ex vivo rat liver homogenate.RESULTS: At all dose levels, 1/T2* remained greater than control values up to 63 days after injection. In the highest dose group, 1/T2* was above control levels during the entire 133 day time-course investigated. There were no quantifiable amounts of NC100150 Injection present 63 days after injection in any of the dose groups. The half-life of NC100150 Injection in rat liver was dose dependent. For the lowest dose group, the degradation of the particles could be defined by a mono-exponential function with a half-life of eight days. For the 2 and 5 mg Fe/kg dose groups, the degradation was bi-exponential with a fast initial decay of seven to eight days followed by a slow terminal decay of 43-46 days.CONCLUSION: NC100150 Injection exhibits prolonged 1/T2* enhancement in rat liver. The liver enhancement persisted at time points when the concentration of iron oxide particles present in the liver was below method detection limits. The prolonged 1/T2* enhancement is likely a result of the particle breakdown products and the induction of ferritin and hemosiderin with increasing iron cores/loading factors.

Added entries (persons, corporate bodies, meetings, titles ...)

  • Hustvedt, Svein Olaf (author)
  • Haldorsen, Anita (author)
  • Bjørnerud, Atle (author)
  • Uppsala universitetInstitutionen för onkologi, radiologi och klinisk immunologi (creator_code:org_t)

Related titles

  • In:Journal of Magnetic Resonance Imaging: Wiley20:4, s. 622-6311053-18071522-2586

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view